Kastritis, Efstathios http://orcid.org/0000-0001-8191-5832
Morel, Pierre
Duhamel, Alain
Gavriatopoulou, Maria
Kyrtsonis, Marie Christine
Durot, Eric
Symeonidis, Argiris
Laribi, Kamel
Hatjiharissi, Evdoxia
Ysebaert, Loic
Vassou, Amalia
Giannakoulas, Nikolaos
Merlini, Giampaolo
Repousis, Panagiotis
Varettoni, Marzia
Michalis, Euridyki
Hivert, Bénédicte
Michail, Michalis
Katodritou, Eirini
Terpos, Evangelos http://orcid.org/0000-0001-5133-1422
Leblond, Veronique
Dimopoulos, Meletios A.
Article History
Received: 25 September 2018
Revised: 27 January 2019
Accepted: 31 January 2019
First Online: 22 May 2019
Compliance with ethical standards
:
: EKastritis has received honoraria from Amgen, Genesis Pharma, Janssen, Takeda, Prothena; PM has consulting or advisory role to Janssen; AD has consulting or advisory role to MSD; LY has received honoraria from Abbvie, Janssen, Roche, Gilead and has consulting or advisory role to Abbvie, Roche, Janssen, Gilead, has research funding from Roche & Janssen; KL has received honoraria from Novartis, has consulting or advisory role with Takeda, Amgen, Gilead, Novartis and has received research funding from Roche, Novartis, Takeda, Sandoz, Teva, Mundipharma; EH has received honoraria from Janssen, Roche, Winmedica; MV has advisory role to Janssen and Roche; NG has received honoraria from Takeda, Amgen, Janssen, Genesis Pharma and has a consulting or advisory role to Takeda, Amgen, Janssem, Genesis Pharma; GM has participated in advisory boards of Janssen, Takeda, Ionis, MAD has received honoraria from Amgen, Celgene, Janssen, Takeda. The remaining authors declare that they have no conflict of interest.